Literature DB >> 2212017

Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

M G Seikaly1, B S Arant, F D Seney.   

Abstract

To examine angiotensin (ANG) concentrations in fluid compartments near known intrarenal ANG receptors, we measured ANG concentrations in glomerular filtrate (GF), star vessel plasma (SVP), and luminal fluid from the early, mid, and late proximal tubule (E, M, and L PT). Samples were collected from euvolemic Munich-Wistar rats by free-flow micropuncture; ANG concentrations were measured by RIA. In one group of rats, concentrations of total immunoreactive ANG (reflecting ANG II and lesser amounts of three fragments) in GF and E, M, and L PT fluid averaged 29-40 nM compared with 32 pM in systemic plasma. In a second group, immunoreactive ANG concentrations in SVP also exceeded systemic levels by a factor of 1,000. In a final group, samples of GF and LPT fluid were purified by HPLC before RIA to measure ANG II and III concentrations specifically: their respective concentrations were 6-8 nM and 14-25 nM. We interpret these results to indicate that substantial amounts of ANG peptides are released into or generated within intrarenal fluid compartments, in which local ANG is likely to effect regulation of renal function independently of systemic ANG.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212017      PMCID: PMC296870          DOI: 10.1172/JCI114846

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat.

Authors:  B D Myers; W M Deen; B M Brenner
Journal:  Circ Res       Date:  1975-07       Impact factor: 17.367

2.  Mechanism of renal handling of angiotensin II in the dog.

Authors:  S Oparil; M D Bailie
Journal:  Circ Res       Date:  1973-11       Impact factor: 17.367

3.  Comparative studies on angiotensins. II. Structure of rat angiotensin and its identification by DNS-method.

Authors:  T Nakayama; T Nakajima; H Sokabe
Journal:  Chem Pharm Bull (Tokyo)       Date:  1972-07       Impact factor: 1.645

4.  Removal of angiotensins from the systemic circulation.

Authors:  P Biron; P Meyer; J C Panisset
Journal:  Can J Physiol Pharmacol       Date:  1968-03       Impact factor: 2.273

5.  Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney.

Authors:  P J Harris; J A Young
Journal:  Pflugers Arch       Date:  1977-01-17       Impact factor: 3.657

6.  Feedback control of glomerular blood flow, pressure, and filtration rate.

Authors:  F S Wright; J P Briggs
Journal:  Physiol Rev       Date:  1979-10       Impact factor: 37.312

7.  Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat.

Authors:  R C Blantz; K S Konnen; B J Tucker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Angiotensin II in arterial and renal venous plasma and renal lymph in the dog.

Authors:  M D Bailie; F C Rector; D W Seldin
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

9.  Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins.

Authors:  P E Ward; E G Erdös; C D Gedney; R M Dowben; R C Reynolds
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

10.  Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade.

Authors:  F A Mendelsohn
Journal:  Clin Sci (Lond)       Date:  1979-08       Impact factor: 6.124

View more
  94 in total

1.  Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.

Authors:  A Quan; M Baum
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

2.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Authors:  Wei Cao; Jie Xu; Zhan Mei Zhou; Guo Bao Wang; Fan Fan Hou; Jing Nie
Journal:  Antioxid Redox Signal       Date:  2012-07-30       Impact factor: 8.401

Review 3.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 4.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

5.  Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model.

Authors:  Arul Veerappan; Alicia C Reid; Nathan O'Connor; Rosalia Mora; Jacqueline A Brazin; Racha Estephan; Takashi Kameue; Jie Chen; Diane Felsen; Surya V Seshan; Dix P Poppas; Thomas Maack; Randi B Silver
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-28

6.  Real-time Imaging of Ca-handling in Intact Renal Glomeruli Using Confocal Microscopy.

Authors:  Muhammad Nabeel Ghayur; Luke Jeffrey Janssen
Journal:  Med Hypotheses Res       Date:  2009-07

Review 7.  The role of angiotensin II-stimulated renal tubular transport in hypertension.

Authors:  Kevin D Burns; Ningjun Li
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

8.  Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

9.  In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys.

Authors:  I A Darby; C Sernia
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

Review 10.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.